News releases - Merck.com
Dec 16, 2024 · Review the archive of Merck's news releases.
Merck Enters into Exclusive Global License Agreement with …
4 days ago · Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist. “We continue to leverage science-driven business …
Merck signs weight loss pill licensing deal with Hansoh Pharma
5 days ago · Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.
Merck discontinues development of 2 experimental cancer drugs …
6 days ago · Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials. ... Reuters, the news and media division of Thomson Reuters, is the ...
News & Stories - Merck
6 days ago · Check out the latest Merck news and stories! Learn more about the leading science and technology company here.
Merck Announces Second-Quarter 2024 Financial Results
Jul 30, 2024 · RAHWAY, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2024. “Our business is demonstrating strong momentum as we exit the first half of the year,” said Robert M. Davis, chairman and chief executive officer, Merck.
FDA approves Merck's drug for rare, deadly lung condition
Mar 26, 2024 · Merck has said it expects those trials to finish around 2025 and 2026. The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda...
Merck & Co., Inc. (MRK) Latest Stock News & Headlines
Get the latest Merck & Co., Inc. (MRK) stock news and headlines to help you in your trading and investing decisions.
Merck Enters Two Strategic Collaborations to Strengthen AI …
Sep 20, 2023 · Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts.
Merck’s Biologics License Application for clesrovimab accepted by …
6 days ago · Merck (MRK) announced the FDA has accepted the Biologics License Application, or BLA, for clesrovimab, the company’s investigational prophylactic long-acting monoclonal antibody designed to ...